Summary The human EB1 gene product was recently found. by a yeast two-hybrid screening. to be associated with the carboxy terminus of the APC (adenomatous polyposis coli) protein, the product of a tumour-suppressor gene thought to act as a gatekeeper in colorectal carcinogenesis. Because virtually all of the APC mutations result in the synthesis of carboxy-terminal truncated proteins, mutant APC proteins are expected to lose their ability to interact with EB1 gene product. Thus, the interaction between APC and EB1 proteins may be important for the tumour-suppressor activity of APC protein, and raises the hypothesis that EB1 is also involved in sporadic colorectal tumonrgenesis. To investigate this hypothesis, somatic mutations in the entire coding sequence of EB1 cDNA were searched by reverse transcriptase singlestrand conformational polymorphism (SSCP) analysis in 21 sporadic colorectal cancers and seven adenomas. None of these tumours contained somatic mutation, whereas a silent cDNA variant was identified in 14% of alleles. Furthermore, to investigate whether EB1 locus was included within a region subjected to losses of heterozygosity, four polymorphism markers surrounding EB1 locus were surveyed. Onty one out of 28 colorectal tumours contained a loss of heterozygosity at the D20S107 marker. In conclusion. the present findings strongly suggest that EB1 gene is not invotved in somatic colorectal carcinogenesis.
The adenomatous polposis coli gene (APC) on chromosome 5q2.1 encodes a tumour suppressor w-hich is assumed to act as a gatekeeper in colorectal carcinogenesis . The APC gene is mutated in about 75%c of colon cancer cell lines (Smith et al. 1993 ) and 60%c of sporadic colorectal cancers (Mlisoshi et al. 1992 : Posell et al. 1992 : Mis-aki et al. 1994 . In these tumours. APC mutations are thouaht to be an earlv event as thev have been found in small benign adenomas (Powell et al. 1992 ). as well as in putative precursor of colorectal adenomas. i.e. aberrant crypt foci (Smith et al. 1994a ). In addition. inherited mutations of APC gene are responsible for familial adenomatous poly-posis. an autosomal dominant disorder that predisposes to earlN deselopment of colorectal cancer (Groden et al. 1991 : Kinzler et al. 1991 . Both germline and somatic mutations are almost exclusiv elv nonsense or frameshift mutations encoding for truncated APC proteins lacking their carboxy -terminal half (Nagase et al. 1993 : De Vries et al. 1996 .
The APC gene encodes a cvtoplasmic 2843-amino-acid protein which is beliesed to act as a tumour suppressor. blocking the cell cycle progression in G (Baeg, et al. 1995) and precipitating entry into apoptosis of the colorectal epithelial cells (Monn et al. 1996) includinc P-catenin (Rubinfeld et al. 1993 : Su et al. 1993 ). plak-oalobin (y-catenin) (Shibata et al. 1994) . tubulin (Munemitsu et al. 1994 : Smith et al. 1994b ). gl-cogen svnthase kinase-31 (a mammalian homologue of ZW-3 kinase) (Rubinfeld et al. 19961 . hDLG (a homologue of the Drosophila disc large tumoursuppressor gene) (Matsumine et al. 1996 ) and a human protein named EB I (Su et al. 1995) .
EBI gene on chromosome 20q 1 1.2 encodes for a nos el 268-amino-acid protein which has been found to associate w-ith the carboxyv-terminus of APC protein (codons 2167-2843) through a y east tu-o-hvbrid screening (Su et al. 1995) . Recent immunoprecipitation assay have showsn that EB1 product can also associate with -catemnn (Monn et al. 1996) . Ahich has been found to participate in the Wg/Wnt cell proliferation pathws ay. EB 1 protein shares little sequence similarity to other proteins except a calcium channel from carp. the bactenral RNA pol merase 6-chain. the Saccharomvces cerevisiae gene product YerO16p (Su et al. 1995) and the closely related gene RPI (Renner et al. 1997 Sesen tubular colorectal adenomas containing, severe dysplasia in fise cases and moderate dysplasia in two other cases wvere also anals sed. Five adenomas were located in the right colon. and txo were located in the left colon. The sporadic nature of these tumours was supported by the following criteria: (1) absence of tumour microsatellite instabilitv searched Awith three A-mononucleotide repeat loci (BATRII. BAT26 and BAT40) essentially as described elsewhere (Markowitz et al. 1995 : Liu et al. 1996 : (2) presence of fewer than fi e colorectal adenomas: (3) and absence of
Amsterdam's criteria in the patient's pedigree (Vasen et al. 1991 Figure 1 Schematic locabon of pnmers pairs used for RT-SSCP analysis of the EB1 cDNA coding sequence. The open box represents the coding region of EB1 cDNA, whereas the 5' and 3' untranslated regions are shown as shaded boxes. The location of the different pnmers are indicated in brackets. The amplificabon was successively performed by amplifying the entire coding sequence using the pnmers S1 and AS3, then re-amplifying the PCR product into three overapping segments using the primer pairs Sl-AS1, S2-AS2 or
S3-AS3
Reverse transcription-polymerase chain reaction (RT-PCR) Total RNAs were isolated and purified usinr the modified guani- The following primers pairs were designed to amplify the entire EBI coding sequence in three overlapping segments ( Figure  1 ): S I (sense). 5'-CGAGACGAAGACGGAACC-3'. and AS I (antisense). 5'-AT-l-lGTCAACACCCATTCTCT-3': S2 (sense). 5'-CACGAGTACATCCAGAACT-T-3'. and AS2 (antisense). 5'-AGGGTTCTTTCGCACCACAC-3': S3 (sense). 5'-CCAGAG-GCCCATCTCAAC-3'. and AS3 (antisense). 5'-CCGATGT-TGCTCTGCTGGT-3'. To improve the specificity of the polymerase chain reaction (PCR). the reaction was successively performed by amplifying the entire coding sequence using the SI and AS3 primers. then reamplifying the PCR products with the primer pairs Sl-ASl. S2 Sequence analysis PCR products displaying abnormal pattern were purified using Microspin columns (Pharmacia. Uppsala. Sweden). and directly sequenced with the deoxytermination method using fluorescently tagged dideoxyribonucleoside (Applied Biosystems. Foster City. CA. USA) on the Applied Biosystems model 373A DNA sequencer. The sequences were compared with the published human EB1 cDNA sequence (Genbank accession number U24166) using the Sequence Navigator package (Applied Biosystems).
Analysis of allelic loss
To determine whether EBI was included within a region undergoing losses of heterozygosity in colorectal cancers. DNA from dissected frozen tumour specimens and normal corresponding tissues were extracted using standard methods (Maniatis et al. 1989 ) and subjected to PCR amplification of the polymorphic microsatellite markers surrounding EBI at loci D20S112 (AFM197xbl12 ). D20S195 (AFM321xcl). D20S107 (AFMI42xh4) and D20S178 (AFM240vd6) (Chumahov et al. 1995) . After amplification for 40 cycles with annealing temperature at 50°C and incorporation of [ax-P]dATP. PCR products were separated on 6% denaturing polyacrylamide gels (acrylamide. N-N'-bisacrylamide: 28:2). and autoradiography was performed.
Allelic loss was scored if the autoradiographic signal was at least 50% reduced when compared with the corresponding normal allele.
RESULTS AND DISCUSSION
To improve the specificity of the reaction. EB I cDNA was amplified in two steps. In the first step. the entire coding, sequence was amplified using the primers SI and AS3 in 28 sporadic colorectal tumour specimens and normal corresponding tissues.
Amplification gave a unique product of 897 bp. indicating the lack of abnormal splicing of EB1 mRNA. In the second step. SSCP analysis of both tumour and normal specimens was performed by reamplifying the previous PCR products with the primer pairs S1-ASI, S12-AS2 or S3-AS3. No change in the electrophoretic mobility was found in colorectal cancer specimens only. indicating the lack of somatic mutation. Seven tumours and normal corresponding specimens contained sequence alterations of the S3-AS3 fragment as shifts in the electrophoretic mobility of singlestranded conformers (Figure 2A ). Sequence analysis found a silent polymorphism changing a C to T in the third base of codon 191 (191-F to 191-P) (Figure 2B ). No additional difference with the published sequence was found when sequencing the entire coding sequence of EBJ.
To determine whether EBI locus. which maps on chromosome 2Oq 1 1.2 (Su et al. 1995) . was subjected to losses of heterozygosity. four polymorphic microsatellite markers surrounding the EBI locus were amplified in both tumour and normal DNAs. The British Joumal of Cancer (1998) (Hiltunen et al. 1997) . and hMLHI (Kane et al. 1997 ).
In conclusion. the present data suggests that EBI is not involved in the development of human sporadic colorectal cancers.
Note added in proof
Since the submission of this article. EB 1 product has been shown to localize to microtubules in i-vo. in both fission (Beinhauer et al. 1997 ) and buddinga yeast (Schwartz et al. 1997 ). In addition. the function of EB 1 product has been recently clarified in yeast (Muhua et al. 1998 
